Arcus Biosciences, Inc.
RCUS- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001724521
In the last 90 days, Arcus Biosciences, Inc. insiders filed 0 open-market purchases and 2 sales; 231 institutions reported holding it in 13F filings for Q2 2026, worth $3.78B in total; no superinvestor holds it.
13F holders, Q1 2022
Institutional positions in Arcus Biosciences, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 157
- +15 vs. Q4 2021
- Shares held
- 50.6M
- −201.2K (−0.4%) vs. Q4 2021
- Total value
- $1.60B
- −$458.0M (−22.3%) vs. Q4 2021
- New holders
- 34
- 44 more added
- Sold out
- 19
- 55 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RCUS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 231 | $3.78B |
| Q1 2026 | 211 | $2.57B |
| Q4 2025 | 209 | $2.89B |
| Q3 2025 | 190 | $1.37B |
| Q2 2025 | 186 | $811.5M |
| Q1 2025 | 187 | $763.3M |
| Q4 2024 | 186 | $1.25B |
| Q3 2024 | 187 | $815.7M |
| Q2 2024 | 193 | $790.9M |
| Q1 2024 | 172 | $997.7M |
| Q4 2023 | 185 | $1.01B |
| Q3 2023 | 187 | $947.9M |
| Q2 2023 | 181 | $1.11B |
| Q1 2023 | 180 | $1.01B |
| Q4 2022 | 200 | $1.11B |
| Q3 2022 | 183 | $1.37B |
| Q2 2022 | 173 | $1.33B |
| Q1 2022 | 157 | $1.60B |
| Q4 2021 | 142 | $2.06B |
| Q3 2021 | 131 | $1.68B |
| Q2 2021 | 130 | $1.24B |
| Q1 2021 | 148 | $1.25B |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Arcus Biosciences, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Swiss National Bank | 91,296 | $2.88M | 0.00% | +4,800+5.5% | Added |
| SG Americas Securities, LLC | 94,186 | $2.97M | 0.03% | +68,297+263.8% | Added |
| Squarepoint Ops LLC | 101,696 | $3.21M | 0.02% | +84,281+484.0% | Added |
| Bellevue Group AG | 111,700 | $3.52M | 0.04% | +24,200+27.7% | Added |
| American Century Companies Inc | 117,715 | $3.71M | 0.00% | +1,911+1.7% | Added |
| AXA S.A. | 134,515 | $4.25M | 0.01% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 134,651 | $4.25M | 0.01% | +78,124+138.2% | Added |
| Bank of America Corp | 137,461 | $4.34M | 0.00% | +39,989+41.0% | Added |
| DAFNA Capital Management LLC | 145,217 | $4.58M | 1.19% | +28,017+23.9% | Added |
| Two Sigma Advisers, LP | 154,800 | $4.88M | 0.01% | −121,200−43.9% | Reduced |
| Rafferty Asset Management, LLC | 161,554 | $5.10M | 0.03% | +35,236+27.9% | Added |
| Panagora Asset Management Inc | 164,303 | $5.18M | 0.03% | +8,684+5.6% | Added |
| Parkman Healthcare Partners LLC | 167,321 | $5.28M | 1.55% | +50,222+42.9% | Added |
| Marshall Wace, LLP | 178,565 | $5.64M | 0.01% | +178,565 | New |
| Sessa Capital IM, L.P. | 181,000 | $5.71M | 0.35% | +181,000 | New |
| Laurion Capital Management LP | 181,244 | $5.72M | 0.14% | +181,244 | New |
| Bain Capital Public Equity Management II, LLC | 187,572 | $5.92M | 0.24% | −235,193−55.6% | Reduced |
| UBS Group AG | 193,879 | $6.12M | 0.00% | +188,069+3,237.0% | Added |
| Tang Capital Management LLC | 200,000 | $6.31M | 1.28% | +200,000 | New |
| Deutsche Bank AG | 201,136 | $6.35M | 0.00% | −2,357−1.2% | Reduced |
| Bank of New York Mellon Corp | 210,835 | $6.65M | 0.00% | −29,229−12.2% | Reduced |
| Connor, Clark & Lunn Investment Management Ltd. | 212,743 | $6.71M | 0.03% | −53,800−20.2% | Reduced |
| Granahan Investment Management Inc | 226,050 | $7.13M | 0.18% | +88,663+64.5% | Added |
| Goldman Sachs Group Inc | 246,440 | $7.78M | 0.00% | +133,979+119.1% | Added |
| Morgan Stanley | 250,630 | $7.91M | 0.00% | −1,183,774−82.5% | Reduced |
| Woodline Partners LP | 261,419 | $8.25M | 0.14% | −1,445,006−84.7% | Reduced |
| Nuveen Asset Management, LLC | 258,002 | $8.93M | 0.00% | −1,224−0.5% | Reduced |
| Gilder Gagnon Howe & Co LLC | 291,280 | $9.19M | 0.08% | −1,388−0.5% | Reduced |
| Invesco Ltd. | 293,474 | $9.26M | 0.00% | +94,844+47.7% | Added |
| UBS Asset Management Americas Inc | 313,838 | $9.90M | 0.00% | +72,627+30.1% | Added |
| Charles Schwab Investment Management Inc | 330,651 | $10.4M | 0.00% | +8,501+2.6% | Added |
| Sectoral Asset Management Inc | 338,480 | $10.7M | 1.90% | +55,270+19.5% | Added |
| Macquarie Group Ltd | 379,880 | $12.0M | 0.01% | 00.0% | Unchanged |
| Perceptive Advisors LLC | 405,000 | $12.8M | 0.27% | +405,000 | New |
| JPMorgan Chase & Co | 435,793 | $13.8M | 0.00% | +167,381+62.4% | Added |
| Dimensional Fund Advisors LP | 437,969 | $13.8M | 0.00% | +190,527+77.0% | Added |
| Northern Trust Corp | 600,408 | $18.9M | 0.00% | −23,862−3.8% | Reduced |
| Franklin Resources Inc | 755,755 | $23.9M | 0.01% | −427,766−36.1% | Reduced |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 797,091 | $25.2M | 0.09% | −64,203−7.5% | Reduced |
| Geode Capital Management, LLC | 797,542 | $25.2M | 0.00% | +28,030+3.6% | Added |
| TimesSquare Capital Management, LLC | 822,012 | $25.9M | 0.29% | −142,770−14.8% | Reduced |
| Decheng Capital Management III (Cayman), LLC | 869,790 | $27.5M | 8.41% | +869,790 | New |
| Avidity Partners Management LP | 912,000 | $28.8M | 0.64% | +912,000 | New |
| Alliancebernstein L.P. | 1,069,943 | $33.8M | 0.01% | +1,025,643+2,315.2% | Added |
| Boxer Capital, LLC | 1,432,200 | $45.2M | 2.32% | 00.0% | Unchanged |
| Pictet Asset Management SA | 1,555,012 | $49.1M | 0.06% | −93,978−5.7% | Reduced |
| Invus Financial Advisors, LLC | 1,612,077 | $50.9M | 22.64% | 00.0% | Unchanged |
| Octagon Capital Advisors LP | 2,489,974 | $78.6M | 16.99% | +394,743+18.8% | Added |
| Alphabet Inc. | 2,563,441 | $80.9M | 2.62% | 00.0% | Unchanged |
| State Street Corp | 2,749,919 | $86.8M | 0.00% | +557,988+25.5% | Added |
| EcoR1 Capital, LLC | 3,265,101 | $103.0M | 3.23% | −2,258,257−40.9% | Reduced |
| FMR LLC | 3,320,514 | $104.8M | 0.01% | +127,118+4.0% | Added |
| PFM Health Sciences, LP | 3,431,010 | $108.3M | 4.18% | 00.0% | Unchanged |
| Vanguard Group Inc | 3,512,114 | $110.8M | 0.00% | +85,778+2.5% | Added |
| BVF Inc | 3,960,948 | $125.0M | 5.00% | +562,881+16.6% | Added |
| BlackRock Inc. | 4,139,526 | $130.6M | 0.00% | +9,597+0.2% | Added |
| Advisor Group Holdings, Inc. | 1,000 | – | – | 00.0% | Unchanged |
| Healthcare of Ontario Pension Plan Trust Fund | 0 | $0 | 0.00% | −370,597−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −160,336−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −149,730−100.0% | Sold out |
| Voloridge Investment Management, LLC | 0 | $0 | 0.00% | −94,938−100.0% | Sold out |
| EAM Investors, LLC | 0 | $0 | 0.00% | −76,163−100.0% | Sold out |
| Toronto Dominion Bank | 0 | $0 | 0.00% | −56,013−100.0% | Sold out |
| EAM Global Investors LLC | 0 | $0 | 0.00% | −49,498−100.0% | Sold out |
| Cooper Creek Partners Management LLC | 0 | $0 | 0.00% | −28,342−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −24,900−100.0% | Sold out |
| Natixis | 0 | $0 | 0.00% | −15,100−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −11,455−100.0% | Sold out |
| Caxton Associates LP | 0 | $0 | 0.00% | −11,387−100.0% | Sold out |
| Wexford Capital LP | 0 | $0 | 0.00% | −9,800−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −9,783−100.0% | Sold out |
| Winton Group Ltd | 0 | $0 | 0.00% | −6,910−100.0% | Sold out |
| Quantamental Technologies LLC | 0 | $0 | 0.00% | −5,793−100.0% | Sold out |
| PDT Partners, LLC | 0 | $0 | 0.00% | −5,051−100.0% | Sold out |
| TriaGen Wealth Management LLC | 0 | $0 | 0.00% | −5,000−100.0% | Sold out |
| CWM, LLC | 0 | $0 | 0.00% | −10−100.0% | Sold out |